Overview

Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of HL140 in patients with primary hypercholesterolemia.
Phase:
Phase 3
Details
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Treatments:
Ezetimibe
Rosuvastatin Calcium